Single Patient Protocol of the Combination of the Oral RET Inhibitor LOXO 292 with the Oral EGFR Inhibitor Osimertinib in a Subject with Treatment Refractory, Metastatic RET Rearranged Non Small Cell Lung Cancer

Gender
Any

Age Group
Any

At a Glance

IRB#IRB18-1588

Lead PhysicianJyoti Patel

Collaborator(s)N/A

EligibilityNot Recruiting